Cargando…
Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival
PURPOSE: To evaluate safety, local oncological control, long-term outcome and potential prognostic factors of stereotactic RFA (SRFA) for the treatment of BCLMs. METHODS: Between July 2003 and December 2019, 42 consecutive female patients with median age 54.0 years were treated with SRFA at our inst...
Autores principales: | Schullian, Peter, Johnston, Edward, Laimer, Gregor, Putzer, Daniel, Eberle, Gernot, Scharll, Yannick, Ianetti-Hackl, Claudia, Bale, Reto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249280/ https://www.ncbi.nlm.nih.gov/pubmed/33825059 http://dx.doi.org/10.1007/s00270-021-02820-6 |
Ejemplares similares
-
Reliability of Stereotactic Radiofrequency Ablation (SRFA) for Malignant Liver Tumors: Novice versus Experienced Operators
por: Schullian, Peter, et al.
Publicado: (2023) -
Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors
por: Schullian, Peter, et al.
Publicado: (2020) -
Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
por: Schullian, Peter, et al.
Publicado: (2019) -
Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
por: Laimer, Gregor, et al.
Publicado: (2020) -
Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience
por: Schullian, Peter, et al.
Publicado: (2020)